Moderna (MRNA) call put ratio 2.4 calls to 1 put after Phase 1 coronavirus vaccine data

Moderna (NASDAQ: MRNA) May weekly call option implied volatility is at 216, June is at 133; compared to its 52-week range of 50 to 172 after Moderna said its experimental COVID-19 vaccine showed promise in a small early-stage trial, with the vaccine producing virus-neutralizing antibodies similar to that found in recovered patients.

You May Also Be Interested In

• Micron Technology (MU) call put ratio 1.2 calls to 1 put into quarter results
• Genco Shipping & Trading Limited (GNK) 8400 contracts of August 30 calls trade, share price up 5.5%
• Hyliion Holdings (HYLN) call put ratio 6.3 calls to 1 put with a focus on July 5, 8 and 15 calls as share price down 7.1%